Related Experiment Video
Updated: May 21, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Therapies in Parkinson's disease
Joseph Jankovic1, Werner Poewe
1Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas 77030, USA. josephj@bcm.edu
Current Opinion in Neurology
|June 14, 2012
Summary
Current Parkinson's disease treatments focus on symptom management, not disease modification. Early diagnosis and a patient-centered approach improve quality of life through exercise and optimized dopaminergic therapy.
Area of Science:
- Neurology
- Pharmacology
- Rehabilitation Medicine
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms.
- Current therapeutic strategies primarily focus on symptomatic relief due to the lack of disease-modifying treatments.
Purpose of the Study:
- To review current evidence-based therapeutic strategies for Parkinson's disease.
- To emphasize a patient-centered approach for managing both motor and non-motor symptoms.
- To discuss recent advances in symptomatic and surgical treatments.
Main Methods:
- Review of recent clinical trials and studies on Parkinson's disease therapeutics.
- Analysis of pharmacological interventions, including monoamine oxidase type B inhibitors, dopamine agonists, and novel drug formulations.
- Evaluation of exercise, physical measures, and surgical interventions like deep brain stimulation.
Main Results:
- Disease-modifying approaches have shown disappointing results in clinical trials.
- Significant advances have been made in symptomatic treatments for Parkinson's disease.
- Early initiation of exercise and physical measures, alongside optimized dopaminergic therapy, improves quality of life.
Conclusions:
- A patient-centered approach, including early diagnosis and intervention, is crucial for managing Parkinson's disease.
- Optimizing dopaminergic therapy and addressing motor/non-motor complications enhance health-related quality of life.
- While disease modification remains elusive, symptomatic and surgical treatments offer substantial benefits.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...